Innovative Trials wins the Queen’s Award
September 20, 2021 | Awards, Queens Award, clinical trials, patient recruitment
Innovative Trials presented with Queen’s Award for international excellence in clinical trial patient recruitment
Innovative Trials, a company specialising in clinical trial patient recruitment and community engagement, has been honoured with a Queen’s Award for Enterprise for its outstanding work, both in the UK and internationally, to help pharmaceutical companies and Clinical Research Organisations (CROs) bring new medicines to market.
The award, which was presented to Kate Shaw and David Watkins, co-founders of Innovative Trials, at the company’s headquarters on Friday 26 June, is a mark of business excellence with winners personally approved by Her Majesty The Queen.
Kate Shaw, Innovative Trials’ co-founder and CEO, said: “We’re delighted and humbled to receive a Queen’s Award for Enterprise in the field of International Trade. Everything we do is driven by the desire to get life-changing treatments to patients faster, so we work extremely hard to support our clients’ needs across the globe. We know how vital new medicines are to patients, especially as our understanding of conditions increase and treatments get more targeted, and how costly recruitment delays can be for those funding the trials, so we do everything in our power to ensure clinical research studies have the participants they need to reach a successful endpoint.
“In the ten years that Innovative Trials has been running so far, we have helped recruit and retain around 40,000 people into clinical trials. It’s something we are incredibly proud of and why it is fantastic to now receive a royal seal of approval for our work.”
Founded in 2010, Innovative Trials works with some of the biggest pharmaceutical companies and CROs globally to help them reach their patient recruitment targets for trials, keep patients engaged throughout the research process and avoid costly delays in bringing effective new treatments to market. To date, the company has worked on nearly 200 clinical trials and played a part in six new treatments being approved for patients across the world. In 2020, the company launched a campaign alongside COUCH Health and Egality to ensure patients from under-represented ethnic groups are fairly represented in clinical research.
The Queen’s Awards for Enterprise recognise and celebrate business excellence in the UK. They are the most prestigious business awards in the country, with winners selected for their outstanding success. It is an endorsement of the highest standard and, for Innovative Trials, will remain in place until 2025.
About The Queen’s Award
The Queen’s Awards for Enterprise recognise and encourage the outstanding achievements of UK businesses in the fields of:
● Innovation;
● International Trade;
● Sustainable Development; and,
● Promoting Opportunity (through social mobility).
Now in its 55th year, the Queen’s Awards for Enterprise recognise and celebrate business excellence in the UK. They are the most prestigious business awards in the country, with winners selected for their outstanding success.
For more information about the Queen’s Awards for Enterprise, visit www.gov.uk/queens-award-for-enterprise
About Innovative Trials
Founded in 2010, Innovative Trials works alongside pharmaceutical and clinical research organisations to ensure that patients enrol onto clinical trials in a timely manner and are fully informed of what the research will involve for themselves and their families. This enables potential new treatments to come to market as early as possible to provide alternative therapeutic options for present and future patients.
Based in Letchworth Garden City in Hertfordshire, Innovative Trials employs around 64 members of staff in the UK. The company works internationally with a further 70 people stationed overseas in 70 countries to help clinical trial researchers recruit eligible patients and keep them involved.
For more information, visit www.innovativetrials.com
This content was provided by Innovative Trials
Company Details
Latest Content from Innovative Trials
FREE Live Webinar – Diversity in Clinical Trials – 24th February
Innovative Trials, Pfizer and Parexel invite you to attend the live webinar
Three predictions for the clinical trial industry in 2022
Kate Shaw, Innovative Trials Founder & CEO, looks ahead to 2022 by listing three predictions for the clinical trial industry in 2022
World Cancer Day – February 2022
World Cancer Day is celebrated around the world in February in February and innovative Trials wants to take this opportunity to raise awareness around cancer
Personalised medicine: driving a need for greater diversity in clinical trials
Kate Shaw, Innovative Trials' Founder & CEO, investigates one of the biggest challenges facing clinical research today.
Cervical Cancer Prevention Month
In this first 2022 blog, the Innovative Trials' Equality & Diversity committee will be looking at raising awareness around Cervical Cancer
Meet Innovative Trials at SCOPE 2022
Stop by Booth 1015 to meet the Innovative Trials' team during SCOPE 2022
Interview with Kate Shaw, Innovative Trials’ Founder/CEO
2021 has been a very busy year for Innovative Trials and Kate Shaw discusses the main highlights.
Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch
Six ways to improve diversity in clinical trials
Diversity is becoming increasingly important as a focus of clinical trials. This whitepaper gives six approaches that could be implemented to help make diversity a bigger focus on your clinical...